Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 2
1996 4
1997 2
1998 4
1999 3
2000 2
2001 3
2002 16
2003 46
2004 113
2005 151
2006 201
2007 255
2008 304
2009 284
2010 287
2011 325
2012 304
2013 315
2014 305
2015 318
2016 351
2017 355
2018 358
2019 341
2020 302
2021 368
2022 347
2023 342
2024 329
2025 125

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,754 results

Results by year

Filters applied: . Clear all
Page 1
A safety evaluation of aripiprazole in the treatment of schizophrenia.
Preda A, Shapiro BB. Preda A, et al. Expert Opin Drug Saf. 2020 Dec;19(12):1529-1538. doi: 10.1080/14740338.2020.1832990. Epub 2020 Oct 16. Expert Opin Drug Saf. 2020. PMID: 33064050 Review.
AREAS COVERED: We review short-and-long-term clinical trials, meta-analyses of clinical trials and product information pertaining to the safety and efficacy of aripiprazole in adults with schizophrenia. Formulations of aripiprazole reviewed include oral aripipraz …
AREAS COVERED: We review short-and-long-term clinical trials, meta-analyses of clinical trials and product information pertaining to the saf …
Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews.
Fieiras C, Chen MH, Escobar Liquitay CM, Meza N, Rojas V, Franco JVA, Madrid E. Fieiras C, et al. BMJ Evid Based Med. 2023 Feb;28(1):7-14. doi: 10.1136/bmjebm-2021-111804. Epub 2022 Jan 31. BMJ Evid Based Med. 2023. PMID: 35101925 Review.
OBJECTIVES: To assess the effectiveness and safety of risperidone and aripiprazole in children with autism spectrum disorder (ASD). DESIGN AND SETTING: Overview of systematic reviews (SRs). ...CONCLUSIONS: We found that aripiprazole and risperidone probably reduce s …
OBJECTIVES: To assess the effectiveness and safety of risperidone and aripiprazole in children with autism spectrum disorder (ASD). D …
Aripiprazole.
Prommer E. Prommer E. Am J Hosp Palliat Care. 2017 Mar;34(2):180-185. doi: 10.1177/1049909115612800. Epub 2016 Jul 10. Am J Hosp Palliat Care. 2017. PMID: 26589880 Review.
Third-generation atypical antipsychotic drugs have emerged as a potential choice for delirium management. Aripiprazole is a third-generation antipsychotic with a dopamine receptor-binding profile distinct from other second-generation antipsychotics. Aripiprazole act …
Third-generation atypical antipsychotic drugs have emerged as a potential choice for delirium management. Aripiprazole is a third-gen …
Aripiprazole-Associated Oligospermia.
Garip B, Oğur B, Uzun O. Garip B, et al. Am J Ther. 2022 Nov-Dec 01;29(6):e725-e726. doi: 10.1097/MJT.0000000000001246. Epub 2020 Oct 1. Am J Ther. 2022. PMID: 33021544 No abstract available.
Aripiprazole for the treatment of delusional disorders: A systematic review.
Miola A, Salvati B, Sambataro F, Toffanin T. Miola A, et al. Gen Hosp Psychiatry. 2020 Sep-Oct;66:34-43. doi: 10.1016/j.genhosppsych.2020.06.012. Epub 2020 Jun 26. Gen Hosp Psychiatry. 2020. PMID: 32650190
RESULTS: We identified 21 single cases of delusional disorders, mostly somatic type, treated with aripiprazole. All studies reported patient clinical improvements after the beginning of the treatment with aripiprazole. The average dose of aripiprazole was 11. …
RESULTS: We identified 21 single cases of delusional disorders, mostly somatic type, treated with aripiprazole. All studies reported …
Aripiprazole Lauroxil Dosing Regimens: Understanding Dosage Strengths and Injection Intervals.
Sommi RW, Rege B, Wehr A, Faldu S, Du Y, Weiden PJ. Sommi RW, et al. CNS Spectr. 2022 Jun;27(3):262-267. doi: 10.1017/S1092852920002072. Epub 2020 Dec 3. CNS Spectr. 2022. PMID: 33267924 Review.
Aripiprazole lauroxil (AL) is a long-acting atypical antipsychotic approved for the treatment of schizophrenia in adults. ...The relationship between dosage strength (milligram injected), injection interval (time between injection visits), and expected steady-state plasma …
Aripiprazole lauroxil (AL) is a long-acting atypical antipsychotic approved for the treatment of schizophrenia in adults. ...The rela …
Aripiprazole-Induced Skin Reaction.
Castanheira L, Santos R, Lemos M, Fernandes E, Reis E, Ferreira D, Pereira JM. Castanheira L, et al. Prim Care Companion CNS Disord. 2021 Jul 15;23(4):20l02772. doi: 10.4088/PCC.20l02772. Prim Care Companion CNS Disord. 2021. PMID: 34265875 Free article. No abstract available.
Aripiprazole Lauroxil: A Review in Schizophrenia.
Frampton JE. Frampton JE. Drugs. 2017 Dec;77(18):2049-2056. doi: 10.1007/s40265-017-0848-4. Drugs. 2017. PMID: 29177572 Review.
Aripiprazole lauroxil long-acting injectable (LAI) [Aristada()] is an intramuscularly administered, extended-release prodrug of aripiprazole, an established atypical antipsychotic agent that, in terms of its relative position within the class, is at the low end of t …
Aripiprazole lauroxil long-acting injectable (LAI) [Aristada()] is an intramuscularly administered, extended-release prodrug of ar …
Aripiprazole for Post-traumatic Stress Disorder: A Systematic Review.
Britnell SR, Jackson AD, Brown JN, Capehart BP. Britnell SR, et al. Clin Neuropharmacol. 2017 Nov/Dec;40(6):273-278. doi: 10.1097/WNF.0000000000000251. Clin Neuropharmacol. 2017. PMID: 29059134 Review.
OBJECTIVE: The aim of this study was to review the safety and efficacy of aripiprazole as monotherapy and adjunct therapy for the treatment of post-traumatic stress disorder (PTSD). ...CONCLUSIONS: Based on the reviewed literature, aripiprazole is a reasonable thera …
OBJECTIVE: The aim of this study was to review the safety and efficacy of aripiprazole as monotherapy and adjunct therapy for the tre …
5,754 results